Visit iDataResearch.com
  Cardiovascular & Infusion Therapy Newsletter
  July 2018
 
Feature Story:

Over 182,000 Heart Valve Replacements per Year in the United States

One of the most common procedures performed in cardiac surgery is heart valve replacement, which makes up nearly a quarter of the total procedure volume. According to international market research and consulting firm, iData Research, over 182,000 heart valve replacements per year are performed in the United States. The primary method for treating heart valve conditions is through open surgery to place a replacement valve. Surgical heart valve replacement procedures can be performed using tissue or mechanical heart valves. Tissue valves have been gaining popularity over the alternative mechanical valves because...

Read full article online

‘Smart Stent’ Detects Narrowing of Arteries

For every three individuals who have had a stent implanted to keep clogged arteries open and prevent a heart attack, at least one will experience restenosis—the renewed narrowing of the artery due to plaque buildup or scarring—which can lead to additional complications. Now, a team led by UBC electrical and computer engineering professor Kenichi Takahata has developed a type of “smart stent” that monitors even subtle changes in the flow of blood through the artery, detecting the narrowing in its earliest stages and making early diagnosis and treatment possible. “We modified a stent to function as a miniature...

read more}

 

Gore Takes on Abbott with New PFO Stroke Indication

W.L. Gore & Associates has received FDA approval to expand the indication of the Gore Cardioform Septal Occluder to reduce the risk of recurrent ischemic stroke in patients. The device treats patients through the closure of patent foramen ovale (PFO). Cardioform’s previous indication was for the closure of atrial septal defects that are up to 17mm in size. Gore’s Structural Heart Leader, Jake Goble said Cardioform has the potential to redefine stroke prevention. Goble began working for Gore in 2007. It was around that time the company began to explore the possibility of...

read more}

 

Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter

Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its .018” Low-Profile percutaneous transluminal angioplasty (PTA) balloon dilation catheter, designed and indicated for a broad range of peripheral vascular applications. The product is the result of the company’s ongoing investment in a pipeline of highly differentiated whole-product solutions. Surmodics expects to make the product available for distribution in the coming months. This new low-profile product combines ...

read more}

 

InfuSystem Holdings, Inc. Launches InfuSystem Mobile, Innovative Infusion Patient Safety App

InfuSystem Holdings, a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, announced the launch of InfuSystem Mobile, its innovative infusion patient safety app for smartphones and tablets. InfuSystem Mobile will seamlessly connect patients with InfuSystem’s world-class suite of safety products, infusion expertise, and team of registered nurses who are available 24/7. As part of the launch, InfuSystem Mobile was...

read more}

 

Abbott’s Newest Generation of Leading Drug Eluting Stent Receives FDA Approval

Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for XIENCE SierraTM, the newest generation of the company’s gold-standard XIENCE everolimus-eluting coronary stent system. XIENCE stents are among the world’s most-used and studied stents and have an exceptional safety record with low rates of complications. Design and technology advances in this generation of XIENCE include features specifically designed for the treatment of complex blockages that now account for up to...

read more}

 
 
 
  Browse Report Categories  
 

Cardiac Rhythm Management

Cardiac Surgery

Electrophysiology and Ablation Devices

Interventional Cardiology

Infusion Therapy

Peripheral Vascular

Vascular Access

BROWSE ALL

 
 
 

Latest Publications

 
 

Europe Market Report Suite For Cardiac Surgery Devices 2018 - MedSuite

US Market Report Suite For Peripheral Vascular Devices 2018 - MedSuite

US Market Report Suite for Interventional Cardiology Devices 2018 – MedSuite

Europe Market Report Suite for Interventional Cardiology Devices 2018 – MedSuite

US Market Report Suite for Vascular Access Devices and Accessories 2018 – MedSuite

US Market Report Suite for Infusion Therapy Devices 2018 – MedSuite

US Market Report Suite For Cardiac Surgery And Heart Valve Devices 2018 - MedSuite

Mexico Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

Brazil Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

Argentina Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

US Market Report Suite for Video and Integrated Operating Room Equipment 2018 – MedSuite

 
  View More  
   
 
 
 
 

Upcoming Publications

 
 

Mexico Market Report Suite For Dental Prosthetics 2018 - MedSuite

Argentina Market Report Suite For Dental Prosthetics 2018 - MedSuite

Japan Market Report Suite For Spinal Implants and VCF Devices 2018 - MedSuite

Australia Market Report Suite For Spinal Implants and VCF Devices 2018 - MedSuite

Taiwan Market Report Suite For Spinal Implants And Vertebral Compression Fracture Devices 2018 - MedSuite

 
  View More  
     
 
 
 
Search All iData Report Categories
 
  WEBSITE | ABOUT | Blog | CONTACT | STAY CONNECTED facebook twitter linkedin  
 
iData Research | 308 - 4211 Kingsway, Burnaby BC, V5H 1Z6 | Tel: 604-266-6933 | info@idataresearch.net

Click here to unsubscribe from the iData Monthly Newsletter